397 related articles for article (PubMed ID: 29153851)
41. Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex.
Zhang S; Zhong L; Chen B; Pan T; Zhang X; Liang L; Li Q; Zhang Z; Chen H; Zhou J; Luo H; Zhang H; Bai C
Antiviral Res; 2015 Oct; 122():20-7. PubMed ID: 26241003
[TBL] [Abstract][Full Text] [Related]
42. MicroRNAs regulate APOBEC gene expression.
Cao W; Wu W
Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
[TBL] [Abstract][Full Text] [Related]
43. Selective inhibition of APOBEC3 enzymes by single-stranded DNAs containing 2'-deoxyzebularine.
Barzak FM; Harjes S; Kvach MV; Kurup HM; Jameson GB; Filichev VV; Harjes E
Org Biomol Chem; 2019 Nov; 17(43):9435-9441. PubMed ID: 31603457
[TBL] [Abstract][Full Text] [Related]
44. Natural resistance to HIV infection: The Vif-APOBEC interaction.
Malim MH
C R Biol; 2006 Nov; 329(11):871-5. PubMed ID: 17067930
[TBL] [Abstract][Full Text] [Related]
45. Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.
Harari A; Ooms M; Mulder LC; Simon V
J Virol; 2009 Jan; 83(1):295-303. PubMed ID: 18945781
[TBL] [Abstract][Full Text] [Related]
46. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.
Green AM; Weitzman MD
DNA Repair (Amst); 2019 Nov; 83():102700. PubMed ID: 31563041
[TBL] [Abstract][Full Text] [Related]
47. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
[TBL] [Abstract][Full Text] [Related]
48. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.
Orecchini E; Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
Chromosome Res; 2018 Mar; 26(1-2):45-59. PubMed ID: 29396793
[TBL] [Abstract][Full Text] [Related]
49. [Assembly and maturation of HIV-1--targets for new anti-HIV compounds].
Bukrinskaia AG; Vorkunova GK; Burshteĭn ME
Mol Gen Mikrobiol Virusol; 2005; (1):18-23. PubMed ID: 15790028
[TBL] [Abstract][Full Text] [Related]
50. APOBEC: A molecular driver in cervical cancer pathogenesis.
Revathidevi S; Murugan AK; Nakaoka H; Inoue I; Munirajan AK
Cancer Lett; 2021 Jan; 496():104-116. PubMed ID: 33038491
[TBL] [Abstract][Full Text] [Related]
51. Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.
Venkatesan S; Rosenthal R; Kanu N; McGranahan N; Bartek J; Quezada SA; Hare J; Harris RS; Swanton C
Ann Oncol; 2018 Mar; 29(3):563-572. PubMed ID: 29324969
[TBL] [Abstract][Full Text] [Related]
52. The preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genes.
Chen J; MacCarthy T
PLoS Comput Biol; 2017 Mar; 13(3):e1005471. PubMed ID: 28362825
[TBL] [Abstract][Full Text] [Related]
53. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution.
Venkatesan S; Angelova M; Puttick C; Zhai H; Caswell DR; Lu WT; Dietzen M; Galanos P; Evangelou K; Bellelli R; Lim EL; Watkins TBK; Rowan A; Teixeira VH; Zhao Y; Chen H; Ngo B; Zalmas LP; Al Bakir M; Hobor S; Grönroos E; Pennycuick A; Nigro E; Campbell BB; Brown WL; Akarca AU; Marafioti T; Wu MY; Howell M; Boulton SJ; Bertoli C; Fenton TR; de Bruin RAM; Maya-Mendoza A; Santoni-Rugiu E; Hynds RE; Gorgoulis VG; Jamal-Hanjani M; McGranahan N; Harris RS; Janes SM; Bartkova J; Bakhoum SF; Bartek J; Kanu N; Swanton C;
Cancer Discov; 2021 Oct; 11(10):2456-2473. PubMed ID: 33947663
[TBL] [Abstract][Full Text] [Related]
54. Molecular origins of APOBEC-associated mutations in cancer.
Petljak M; Maciejowski J
DNA Repair (Amst); 2020 Oct; 94():102905. PubMed ID: 32818816
[TBL] [Abstract][Full Text] [Related]
55. Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir.
Abdi B; Lambert-Niclot S; Wirden M; Jary A; Teyssou E; Sayon S; Palich R; Tubiana R; Simon A; Valantin MA; Katlama C; Morand-Joubert L; Calvez V; Marcelin AG; Soulie C
J Antimicrob Chemother; 2021 Jul; 76(8):2148-2152. PubMed ID: 33930161
[TBL] [Abstract][Full Text] [Related]
56. Nucleotide Weight Matrices Reveal Ubiquitous Mutational Footprints of AID/APOBEC Deaminases in Human Cancer Genomes.
Rogozin IB; Roche-Lima A; Lada AG; Belinky F; Sidorenko IA; Glazko GV; Babenko VN; Cooper DN; Pavlov YI
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30759888
[TBL] [Abstract][Full Text] [Related]
57. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA.
Bergstrom EN; Luebeck J; Petljak M; Khandekar A; Barnes M; Zhang T; Steele CD; Pillay N; Landi MT; Bafna V; Mischel PS; Harris RS; Alexandrov LB
Nature; 2022 Feb; 602(7897):510-517. PubMed ID: 35140399
[TBL] [Abstract][Full Text] [Related]
58. Targeting APOBECs in cancer: It's about timing.
Hata AN; Larijani M
Cancer Cell; 2024 Apr; 42(4):497-501. PubMed ID: 38593778
[TBL] [Abstract][Full Text] [Related]
59. Evolutionary potential of the monkeypox genome arising from interactions with human APOBEC3 enzymes.
Delamonica B; Davalos L; Larijani M; Anthony SJ; Liu J; MacCarthy T
Virus Evol; 2023; 9(2):vead047. PubMed ID: 37577211
[TBL] [Abstract][Full Text] [Related]
60. Clustered mutations in hominid genome evolution are consistent with APOBEC3G enzymatic activity.
Pinto Y; Gabay O; Arbiza L; Sams AJ; Keinan A; Levanon EY
Genome Res; 2016 May; 26(5):579-87. PubMed ID: 27056836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
